Antithyroid drugs inhibit thyroid hormone receptor-mediated transcription

Journal of Clinical Endocrinology and Metabolism

Volumn 92, Issue 3, 2007, Pages 1066-1072

  Moriyama, Kenji ^a,b   Tagami, Tetsuya ^b,c   Usui, Takeshi ^b   Naruse, Mitsuhide ^b   Nambu, Takuo ^a   Hataya, Yuji ^a   Kanamoto, Naotetsu ^a   Li, Yu Shu ^a   Yasoda, Akihiro ^a   Arai, Hiroshi ^a   Nakao, Kazuwa ^a  

^a KYOTO UNIVERSITY   (Japan)

^b NATIONAL HOSPITAL ORGANIZATION   (Japan)

^c NATIONAL HOSPITAL ORGANIZATION KYOTO MEDICAL CENTER   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH HORMONE; LIOTHYRONINE; NUCLEAR RECEPTOR COACTIVATOR 2; NUCLEAR RECEPTOR COREPRESSOR; PROPYLTHIOURACIL; STEROID RECEPTOR COACTIVATOR 1; THIAMAZOLE; THYROID HORMONE RECEPTOR;

ARTICLE; CONTROLLED STUDY; DRUG ANTAGONISM; DRUG INHIBITION; DRUG STRUCTURE; GENE CONTROL; GENETIC TRANSCRIPTION; HORMONE RELEASE; HORMONE SYNTHESIS; HUMAN; HUMAN CELL; PRIORITY JOURNAL; TRANSCRIPTION INITIATION;

MAMMALIA;

EID: 33947519707     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2006-1621     Document Type: Article

References (45)

1. Cooper DS 1984 Antithyroid drugs. N Engl J Med 311:1353-1362
2. Cooper DS 2005 Antithyroid drugs. N Engl J Med 352:905-917
3. Meredish JH, Rogers H, Johnston FR 1961 Immediate influence of propylthiouracil on oxygen consumption in the dog. Surg Forum 12:5-7
4. Bray GA, Hildreth S 1967 Effect of propylthiouracil and methimazole on the oxygen consumption of hypothyroid rats receiving thyroxine or triiodothyronine. Endocrinology 81:1018-1020
5. Bandyopadhyay U, Biswas K, Banerjee RK 2002 Extrathyroidal actions of antithyroid thionamides. Toxicol Lett 128:117-127
6. Takagi S, Hummel BC, Walfish PG 1990 Thionamides and arsenite inhibit specific T3 binding to the hepatic nuclear receptor. Biochem Cell Biol 68:616-621
7. Umesono K, Murakami KK, Thompson CC, Evans RM 1990 Direct repeats as selective response elements for the thyroid hormone, retinoic acid, and vitamin D receptors. Cell 65:1255-1266
8. Sadowski I, Ma J, Tiezenberg S, Ptashne M 1988 Gal4-VP16 is an unusually potent transcriptional activator. Nature 335:563-564
9. Tagami T, Gu W, Peairs PT, West BL, Jameson JL 1998 A novel natural mutation in the thyroid hormone receptor defines a dual functional domain that exchanges nuclear receptor corepressors and coactivators. Mol Endocrinol 12:1888-1902
10. Desvergne B, Petty KJ, Nikodem VM 1991 Functional characterization and receptor binding studies of the malic enzyme thyroid hormone response element. J Biol Chem 266:1008-1013
11. Tagami T, Lutz WH, Kumar R, Jameson JL 1998 The interaction of the vitamin D receptor with nuclear receptor corepressors and coactivators. Biochem Biophys Res Commun 253:353-363
12. Margolskee RF, McHendry-Rinde B, Horn R 1993 Panning transfected cells for electrophysiological studies. Biotechniques 15:906-911
13. Moriyama K, Tagami T, Akamizu T, Usui T, Saijo M, Kanamoto N, Hataya Y, Simatsu A, Kuzuya H, Nakao K 2002 Thyroid hormone action is disrupted by Bisphenol A as an antagonist. J Clin Endocrinol Metab 87:5185-5190
14. Tagami T, Madison LD, Nagaya T, Jameson JL 1997 Nuclear receptor corepressors activate rather than suppress basal transcription of genes that are negatively regulated by thyroid hormone. Mol Cell Biol 17:2642-2648
15. Horlein AJ, Naar AM, Heinzel T, Torchia J, Gloss B, Kurokawa R, Ryan A, Kamei Y, Soderstrom M, Glass CK, Rosenfeld MG 1995 Ligand-independent repression by the thyroid hormone receptor mediated by a nuclear receptor co-repressor. Nature 377:397-404
16. Chen JD, Evans RM 1995 A transcriptional co-repressor that interacts with nuclear hormone receptors. Nature 377:454-457
17. Tagami T, Park Y, Jameson JL 1999 Mechanisms that mediate negative regulation of the thyroid stimulating hormone gene by the thyroid hormone receptor. J Biol Chem 274:22345-22353
18. Onate SA, Tsai SY, Tsai MJ, O'Malley BW 1995 Sequence and characterization of a coactivator for the steroid hormone receptor superfamily. Science 270:1354-1357
19. Hong H, Kohli K, Garabedian MJ, Stallcup MR 1997 GRIP1, a transcriptional coactivator for the AF-2 transactivation domain of steroid, thyroid, retinoid, and vitamin D receptors. Mol Cell Biol 17:2735-2744
20. Glass CK, Franco R, Weinberger C, Albert VR, Evans RM, Rosenfeld MG 1987 A c-erb-A binding site in rat growth hormone gene mediates transactivation by thyroid hormone. Nature 329:738-741
21. Koenig RJ, Brent GA, Warne RL, Larsen PR, Moore DD 1987 Thyroid hormone receptor binds to a site in the rat growth hormone promoter required for induction by thyroid hormone. Proc Natl Acad Sci USA 84:5670-5674
22. Koenig RJ, Warne RL, Brent GA, Harney JW, Larsen PR, Moore DD 1988 Isolation of a cDNA clone encoding a biologically active thyroid hormone receptor. Proc Natl Acad Sci USA 85:5031-5035
23. Astwood EB 1943 Treatment of hyperthyroidism with thiourea and thiouracil. JAMA 122:78
24. Mackinzie JB, Mackinzie CG, McCollum EV 1941 The effect of sulfanilylguanidine on the thyroid of the rat. Science 94:518
25. Mackinzie CG, Mackinzie JB 1943 The effect of sulfonamides and thiouracil on the thyroid gland and basal metabolism. Endocrinology 32:185
26. Solanes G, Pedraza N, Calvo V, Vidal-Puig A, Lowell BB, Villarroya F 2005 Thyroid hormones directly activate the expression of the human and mouse uncoupling protein-3 genes through a thyroid response element in the proximal promoter region. Biochem J 386:505-513
27. Leer LM, Cammenga M, van der Vorm ER, de Vijlder JJ 1991 Methimazole increases thyroid-specific mRNA concentration in human thyroid cells and FRTL-5 cells. Mol Cell Endocrinol 78:221-228
28. Leer LM, Cammenga M, de Vijlder JJ 1991 Methimazole and propylthiouracil increase thyroglobulin gene expression in FRTL-5 cells. Mol Cell Endocrinol 82:R25-R30
29. Isozaki O, Tsushima T, Emoto N, Saji M, Tsuchiya Y, Demura H, Sato Y, Shizume K, Kimura S, Kohn LD 1991 Methimazole regulation of thyroglobulin biosynthesis and gene transcription in rat FRTL-5 thyroid cells. Endocrinology 128:3113-3121
30. Sugawara M, Sugawara Y, Wen K 1999 Methimazole and propylthiouracil increase cellular thyroid peroxidase activity and thyroid peroxidase mRNA in cultured porcine thyroid follicles. Thyroid 9:513-518
31. Montani V, Shong M, Taniguchi SI, Suzuki K, Giuliani C, Napolitano G, Saito J, Saji M, Fiorentino B, Reimold AM, Singer DS, Kohn LD 1998 Regulation of major histocompatibility class II gene expression in FRTL-5 thyrocyte: opposite effects of interferon and methimazole. Endocrinology 139:290-302
32. Mitsiades N, Poulaki V, Tseleni-Balafouta S, Chrousos GP, Koutras DA 2000 Fas ligand expression in thyroid follicular cells from patients with thionamide-treated Graves' disease. Thyroid 10:527-532
33. Machia E, Nakai A, Janiga A, Sakurai A, Fisfaren ME, Gardner P, Soltani K, DeGroot LJ 1990 Characterization of site-specific polyclonal antibodies to c-erb Apeptides recognizing human thyroid hormone receptors α1, α2, β and native 3,5,3′-triiodothyronine receptor, and study of tissue distribution of the antigen. Endocrinology 126:3232-3239
34. Tagami T, Nakamura H, Sasaki S, Mori T, Yoshioka H, Yoshida H, Imura H 1990 Immunohistochemical localization of nuclear 3,5,3′- triiodothyronine receptor proteins in rat tissues studied with antiserum against c-erb A/T3 receptor. Endocrinology 127:1727-1734
35. Bronnegard M, Torring O, Boos J, Sylven C, Marcus C, Wallin G 1994 Expression of thyrotropin receptor and thyroid hormone receptor messenger ribonucleic acid in normal, hyperplastic, and neoplastic human thyroid tissue. J Clin Endocrinol Metab 79:384-389
36. Lazarus JH, Marchant B, Alexander WD, Clark DH 1975 35-S-antithyroid drug concentration and organic binding of iodine in the human thyroid. Clin Endocrinol (Oxf) 4:609-615
37. Okamura Y, Shigemasa C, Tatsuhara T 1986 Pharmacokinetics of methimazole in normal subjects and hyperthyroid patients. Endocrinology 33:605-615
38. Cooper DS, Saxe VC, Meskell M, Maloof F, Ridgway EC 1982 Acute effects of propylthiouracil (PTU) on thyroidal iodine organization and peripheral iodothyronine deiodination: correlation with serum PTU levels measured by radioimmunoassay. J Clin Endocrinol Metab 54:101-107
39. McKenna NJ, Lanz RB, O'Malley BW 1999 Nuclear receptor coregulators: cellular and molecular biology. Endocr Rev 20:321-344
40. Cohen RN, Wondisford FE, Hollenberg AN 1998 Two separate NCoR (nuclear receptor corepressor) interaction domains mediate corepressor action on thyroid hormone response elements. Mol Endocrinol 12:1567-1581
41. Cohen RN, Putney A, Wondisford FE, Hollenberg AN 2000 The nuclear corepressors recognize distinct nuclear receptor complexes. Mol Endocrinol 14:900-914
42. Cohen RN, Brzostek S, Kim B, Chorev M, Wondisford FE, Hollenberg AN 2001 The specificity of interactions between nuclear hormone receptors and corepressors is mediated by distinct amino acid sequences within the interacting domains. Mol Endocrinol 15:1049-1061
43. Li X, Wong J, Tsai SY, Tsai MJ, O'Malley BM 2003 Progesterone and glucocorticoid receptors recruit distinct coactivator complexes and promote distinct patterns of local chromatin modification. Mol Cell Biol 23:3763-3773
44. Onate SA, Boonyaratanakornkit V, Spencer TE, Tsai SY, Tsai MJ, Edwards DP, O'Malley BW 1998 The steroid receptor coactivator-1 contains multiple receptor interacting and activation domains that cooperatively enhance the activation function 1 (AF1) and AF2 domains of steroid receptors. J Biol Chem 273:12101-12108
45. Mangelsdorf DJ, Evans RM 1995 The RXR heterodimers and orphan receptors. Cell 83:841-850